Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2017

01-12-2017 | Review

Breast cancer in elderly women and altered clinico-pathological characteristics: a systematic review

Authors: M. Lodi, L. Scheer, N. Reix, D. Heitz, A.-J. Carin, N. Thiébaut, K. Neuberger, C. Tomasetto, C. Mathelin

Published in: Breast Cancer Research and Treatment | Issue 3/2017

Login to get access

Abstract

Purpose

Breast cancer is the most common malignancy in women in terms of incidence and mortality. Age is undoubtedly the biggest breast cancer risk factor. In this study we examined clinical, histological, and biological characteristics and mortality of breast cancer in elderly women along with their changes with advancing age.

Methods

We reviewed 63 original articles published between 2006 and 2016 concerning women over 70 years with breast cancer.

Results

Compared to patients 70–79 years, patients aged 80 and over had larger tumor size with fewer T1 (42.9% vs 57.7%, p < 0.01) and more T2 lesions (43.5% vs 33.0%, p < 0.01). Lymph nodes and distant metastases were more frequent, with more N + (49.5% vs 44.0%, p < 0.01) and more M1 (8.0% vs 5.9%, p < 0.01). Infiltrating mucinous carcinomas were more frequent (4.3% vs 3.7%, p < 0.01). Tumors had lower grades, with more grade 1 (23.2% vs 19.8%, p = 0.01) and fewer grade 3 (21.5% vs 25.5%, p < 0.01), and were more hormone-sensitive: PR was more often expressed (72.6% vs 67.3%, p < 0.01). Lympho-vascular invasion was less frequent in the 80 years and over (22.9% vs 29.7%, p = 0.01). Breast cancer-specific mortality was higher both at 5 years (25.8% vs 17.2%, p < 0.01) and 10 years (32.7% vs 26.6%, p < 0.01).

Conclusion

Clinico-pathological characteristics, increased incidence, and mortality associated with aging can be explained on one hand by biological changes of the breast such as increased estrogen sensitivity, epithelial cell alterations, immune senescence, and tumor microenvironment modifications. However, sociologic factors such as increased life expectancy, under-treatment, late diagnosis, and insufficient individual screening, are also involved.
Appendix
Available only for authorised users
Literature
5.
go back to reference Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, Diver WR, Thun MJ, Cox DG, Hankinson SE, Kraft P, Rosner B, Berg CD, Brinton LA, Lissowska J, Sherman ME, Chlebowski R, Kooperberg C, Jackson RD, Buckman DW, Hui P, Pfeiffer R, Jacobs KB, Thomas GD, Hoover RN, Gail MH, Chanock SJ, Hunter DJ (2010) Performance of common genetic variants in breast-cancer risk models. N Engl J Med 362(11):986–993. doi:10.1056/NEJMoa0907727 PubMedPubMedCentralCrossRef Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, Diver WR, Thun MJ, Cox DG, Hankinson SE, Kraft P, Rosner B, Berg CD, Brinton LA, Lissowska J, Sherman ME, Chlebowski R, Kooperberg C, Jackson RD, Buckman DW, Hui P, Pfeiffer R, Jacobs KB, Thomas GD, Hoover RN, Gail MH, Chanock SJ, Hunter DJ (2010) Performance of common genetic variants in breast-cancer risk models. N Engl J Med 362(11):986–993. doi:10.​1056/​NEJMoa0907727 PubMedPubMedCentralCrossRef
6.
go back to reference Colonna M, Mitton N, Grosclaude P (2014) Estimation de la prévalence (partielle et totale) du cancer en France métropolitaine chez les 15 ans et plus en 2008 - Étude à partir des registres des cancers du réseau Francim.. Institut de Veille Saniaire. http://www.cancer-environnement.fr/Portals/0/Documents PDF/Estimation-prevalence-cancer-France-metropolitaine-en-2008-2014.pdf. Accessed October 26, 2016 Colonna M, Mitton N, Grosclaude P (2014) Estimation de la prévalence (partielle et totale) du cancer en France métropolitaine chez les 15 ans et plus en 2008 - Étude à partir des registres des cancers du réseau Francim.. Institut de Veille Saniaire. http://​www.​cancer-environnement.​fr/​Portals/​0/​Documents PDF/Estimation-prevalence-cancer-France-metropolitaine-en-2008-2014.pdf. Accessed October 26, 2016
9.
go back to reference Biganzoli L, Goldhirsch A, Straehle C, Castiglione-Gertsch M, Therasse P, Aapro M, Minisini A, Piccart MJ (2004) Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG). Ann Oncol 15(2):207–210PubMedCrossRef Biganzoli L, Goldhirsch A, Straehle C, Castiglione-Gertsch M, Therasse P, Aapro M, Minisini A, Piccart MJ (2004) Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG). Ann Oncol 15(2):207–210PubMedCrossRef
13.
go back to reference Molinie F, Vanier A, Woronoff AS, Guizard AV, Delafosse P, Velten M, Daubisse-Marliac L, Arveux P, Tretarre B (2014) Trends in breast cancer incidence and mortality in France 1990–2008. Breast Cancer Res Treat 147(1):167–175. doi:10.1007/s10549-014-3073-9 PubMedCrossRef Molinie F, Vanier A, Woronoff AS, Guizard AV, Delafosse P, Velten M, Daubisse-Marliac L, Arveux P, Tretarre B (2014) Trends in breast cancer incidence and mortality in France 1990–2008. Breast Cancer Res Treat 147(1):167–175. doi:10.​1007/​s10549-014-3073-9 PubMedCrossRef
16.
go back to reference Altobelli E, Rapacchietta L, Angeletti PM, Barbante L, Profeta FV, Fagnano R (2017) Breast cancer screening programmes across the WHO European Region: differences among countries based on national income level. Int J Environ Res Public Health. doi:10.3390/ijerph14040452 PubMedPubMedCentral Altobelli E, Rapacchietta L, Angeletti PM, Barbante L, Profeta FV, Fagnano R (2017) Breast cancer screening programmes across the WHO European Region: differences among countries based on national income level. Int J Environ Res Public Health. doi:10.​3390/​ijerph14040452 PubMedPubMedCentral
17.
go back to reference Smith RA, Andrews K, Brooks D, DeSantis CE, Fedewa SA, Lortet-Tieulent J, Manassaram-Baptiste D, Brawley OW, Wender RC (2016) Cancer screening in the United States, 2016: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 66(2):96–114. doi:10.3322/caac.21336 PubMedCrossRef Smith RA, Andrews K, Brooks D, DeSantis CE, Fedewa SA, Lortet-Tieulent J, Manassaram-Baptiste D, Brawley OW, Wender RC (2016) Cancer screening in the United States, 2016: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 66(2):96–114. doi:10.​3322/​caac.​21336 PubMedCrossRef
18.
go back to reference van de Water W, Markopoulos C, van de Velde CJ, Seynaeve C, Hasenburg A, Rea D, Putter H, Nortier JW, de Craen AJ, Hille ET, Bastiaannet E, Hadji P, Westendorp RG, Liefers GJ, Jones SE (2012) Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 307(6):590–597. doi:10.1001/jama.2012.84 PubMed van de Water W, Markopoulos C, van de Velde CJ, Seynaeve C, Hasenburg A, Rea D, Putter H, Nortier JW, de Craen AJ, Hille ET, Bastiaannet E, Hadji P, Westendorp RG, Liefers GJ, Jones SE (2012) Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 307(6):590–597. doi:10.​1001/​jama.​2012.​84 PubMed
19.
go back to reference Barthelemy P, Heitz D, Mathelin C, Polesi H, Asmane I, Litique V, Rob L, Bergerat JP, Kurtz JE (2011) Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals. Crit Rev Oncol Hematol 79(2):196–204. doi:10.1016/j.critrevonc.2010.06.005 PubMedCrossRef Barthelemy P, Heitz D, Mathelin C, Polesi H, Asmane I, Litique V, Rob L, Bergerat JP, Kurtz JE (2011) Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals. Crit Rev Oncol Hematol 79(2):196–204. doi:10.​1016/​j.​critrevonc.​2010.​06.​005 PubMedCrossRef
20.
go back to reference Cortadellas T, Cordoba O, Gascon A, Haladjian C, Bernabeu A, Alcalde A, Esgueva A, Rodriguez-Revuelto R, Espinosa-Bravo M, Diaz-Botero S, Xercavins J, Rubio IT, Gil-Moreno A (2015) Surgery improves survival in elderly with breast cancer. A study of 465 patients in a single institution. Eur J Surg Oncol 41(5):635–640. doi:10.1016/j.ejso.2015.01.027 PubMedCrossRef Cortadellas T, Cordoba O, Gascon A, Haladjian C, Bernabeu A, Alcalde A, Esgueva A, Rodriguez-Revuelto R, Espinosa-Bravo M, Diaz-Botero S, Xercavins J, Rubio IT, Gil-Moreno A (2015) Surgery improves survival in elderly with breast cancer. A study of 465 patients in a single institution. Eur J Surg Oncol 41(5):635–640. doi:10.​1016/​j.​ejso.​2015.​01.​027 PubMedCrossRef
21.
go back to reference Cyr A, Gillanders WE, Aft RL, Eberlein TJ, Margenthaler JA (2011) Breast cancer in elderly women (≥ 80 years): variation in standard of care? J Surg Oncol 103(3):201–206. doi:10.1002/jso.21799 PubMedCrossRef Cyr A, Gillanders WE, Aft RL, Eberlein TJ, Margenthaler JA (2011) Breast cancer in elderly women (≥ 80 years): variation in standard of care? J Surg Oncol 103(3):201–206. doi:10.​1002/​jso.​21799 PubMedCrossRef
22.
go back to reference Dialla PO, Dabakuyo TS, Marilier S, Gentil J, Roignot P, Darut-Jouve A, Poillot ML, Quipourt V, Arveux P (2012) Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment. BMC Cancer 12:472. doi:10.1186/1471-2407-12-472 PubMedPubMedCentralCrossRef Dialla PO, Dabakuyo TS, Marilier S, Gentil J, Roignot P, Darut-Jouve A, Poillot ML, Quipourt V, Arveux P (2012) Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment. BMC Cancer 12:472. doi:10.​1186/​1471-2407-12-472 PubMedPubMedCentralCrossRef
25.
go back to reference Li B, Hua B, Lu X, Chen Y, Xiao WZ (2013) Treatment options for elderly breast cancer patients over 70 years old. Zhonghua Yi Xue Za Zhi 93(44):3523–3525PubMed Li B, Hua B, Lu X, Chen Y, Xiao WZ (2013) Treatment options for elderly breast cancer patients over 70 years old. Zhonghua Yi Xue Za Zhi 93(44):3523–3525PubMed
28.
go back to reference Molino A, Giovannini M, Auriemma A, Fiorio E, Mercanti A, Mandara M, Caldara A, Micciolo R, Pavarana M, Cetto GL (2006) Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Crit Rev Oncol Hematol 59(3):226–233. doi:10.1016/j.critrevonc.2006.01.007 PubMedCrossRef Molino A, Giovannini M, Auriemma A, Fiorio E, Mercanti A, Mandara M, Caldara A, Micciolo R, Pavarana M, Cetto GL (2006) Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Crit Rev Oncol Hematol 59(3):226–233. doi:10.​1016/​j.​critrevonc.​2006.​01.​007 PubMedCrossRef
33.
go back to reference Zhao WH, Xu BH, Li Q, Zhang P, Sun Y (2006) Clinical features and prognosis in breast cancer patients over 70 years of age. Zhonghua Zhong Liu Za Zhi 28(5):385–388PubMed Zhao WH, Xu BH, Li Q, Zhang P, Sun Y (2006) Clinical features and prognosis in breast cancer patients over 70 years of age. Zhonghua Zhong Liu Za Zhi 28(5):385–388PubMed
34.
go back to reference Afsharfard A, Mozaffar M, Orang E, Tahmasbpour E (2013) Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study. Asian Pac J Cancer Prev 14(11):6905–6911PubMedCrossRef Afsharfard A, Mozaffar M, Orang E, Tahmasbpour E (2013) Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study. Asian Pac J Cancer Prev 14(11):6905–6911PubMedCrossRef
37.
38.
go back to reference Cutuli B, Dalenc F, Cottu PH, Gligorov J, Guastalla JP, Petit T, Amrate A (2015) Impact of screening on clinicopathological features and treatment for invasive breast cancer: results of two national surveys. Cancer Radiother 19(5):295–302. doi:10.1016/j.canrad.2015.02.015 PubMedCrossRef Cutuli B, Dalenc F, Cottu PH, Gligorov J, Guastalla JP, Petit T, Amrate A (2015) Impact of screening on clinicopathological features and treatment for invasive breast cancer: results of two national surveys. Cancer Radiother 19(5):295–302. doi:10.​1016/​j.​canrad.​2015.​02.​015 PubMedCrossRef
39.
go back to reference Durbecq V, Ameye L, Veys I, Paesmans M, Desmedt C, Sirtaine N, Sotiriou C, Bernard-Marty C, Nogaret JM, Piccart M, Larsimont D (2008) A significant proportion of elderly patients develop hormone-dependant “luminal-B” tumours associated with aggressive characteristics. Crit Rev Oncol Hematol 67(1):80–92. doi:10.1016/j.critrevonc.2007.12.008 PubMedCrossRef Durbecq V, Ameye L, Veys I, Paesmans M, Desmedt C, Sirtaine N, Sotiriou C, Bernard-Marty C, Nogaret JM, Piccart M, Larsimont D (2008) A significant proportion of elderly patients develop hormone-dependant “luminal-B” tumours associated with aggressive characteristics. Crit Rev Oncol Hematol 67(1):80–92. doi:10.​1016/​j.​critrevonc.​2007.​12.​008 PubMedCrossRef
40.
go back to reference Hancke K, Denkinger MD, Konig J, Kurzeder C, Wockel A, Herr D, Blettner M, Kreienberg R (2010) Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. Ann Oncol 21(4):748–753. doi:10.1093/annonc/mdp364 PubMedCrossRef Hancke K, Denkinger MD, Konig J, Kurzeder C, Wockel A, Herr D, Blettner M, Kreienberg R (2010) Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. Ann Oncol 21(4):748–753. doi:10.​1093/​annonc/​mdp364 PubMedCrossRef
41.
go back to reference Kaur P, Santillan AA, McGuire K, Turaga KK, Shamehdi C, Meade T, Ramos D, Mathias M, Parbhoo J, Davis M, Khakpour N, King J, Balducci L, Cox CE (2012) The surgical treatment of breast cancer in the elderly: a single institution comparative review of 5235 patients with 1028 patients ≥ 70 years. Breast J 18(5):428–435. doi:10.1111/j.1524-4741.2012.01272.x PubMedCrossRef Kaur P, Santillan AA, McGuire K, Turaga KK, Shamehdi C, Meade T, Ramos D, Mathias M, Parbhoo J, Davis M, Khakpour N, King J, Balducci L, Cox CE (2012) The surgical treatment of breast cancer in the elderly: a single institution comparative review of 5235 patients with 1028 patients ≥ 70 years. Breast J 18(5):428–435. doi:10.​1111/​j.​1524-4741.​2012.​01272.​x PubMedCrossRef
42.
go back to reference Ma CD, Zhou Q, Nie XQ, Liu GY, Di GH, Wu J, Lu JS, Yang WT, Chen JY, Shao ZM, Shen KW, Shen ZZ (2009) Breast cancer in Chinese elderly women: pathological and clinical characteristics and factors influencing treatment patterns. Crit Rev Oncol Hematol 71(3):258–265. doi:10.1016/j.critrevonc.2008.11.005 PubMedCrossRef Ma CD, Zhou Q, Nie XQ, Liu GY, Di GH, Wu J, Lu JS, Yang WT, Chen JY, Shao ZM, Shen KW, Shen ZZ (2009) Breast cancer in Chinese elderly women: pathological and clinical characteristics and factors influencing treatment patterns. Crit Rev Oncol Hematol 71(3):258–265. doi:10.​1016/​j.​critrevonc.​2008.​11.​005 PubMedCrossRef
43.
go back to reference Montroni I, Rocchi M, Santini D, Ceccarelli C, Ghignone F, Zattoni D, Nuvola G, Zanotti S, Ugolini G, Taffurelli M (2014) Has breast cancer in the elderly remained the same over recent decades? A comparison of two groups of patients 70 years or older treated for breast cancer twenty years apart. J Geriatr Oncol 5(3):260–265. doi:10.1016/j.jgo.2014.02.006 PubMedCrossRef Montroni I, Rocchi M, Santini D, Ceccarelli C, Ghignone F, Zattoni D, Nuvola G, Zanotti S, Ugolini G, Taffurelli M (2014) Has breast cancer in the elderly remained the same over recent decades? A comparison of two groups of patients 70 years or older treated for breast cancer twenty years apart. J Geriatr Oncol 5(3):260–265. doi:10.​1016/​j.​jgo.​2014.​02.​006 PubMedCrossRef
45.
go back to reference Phua CE, Bustam AZ, Yip CH, Taib NA (2010) Prognostic factors for elderly breast cancer patients in University Malaya Medical Centre, Malaysia. Asian Pac J Cancer Prev 11(5):1205–1211PubMed Phua CE, Bustam AZ, Yip CH, Taib NA (2010) Prognostic factors for elderly breast cancer patients in University Malaya Medical Centre, Malaysia. Asian Pac J Cancer Prev 11(5):1205–1211PubMed
47.
go back to reference Syed BM, Johnston SJ, Wong DW, Green AR, Winterbottom L, Kennedy H, Simpson N, Morgan DA, Ellis IO, Cheung KL (2012) Long-term (37 years) clinical outcome of older women with early operable primary breast cancer managed in a dedicated clinic. Ann Oncol 23(6):1465–1471. doi:10.1093/annonc/mdr446 PubMedCrossRef Syed BM, Johnston SJ, Wong DW, Green AR, Winterbottom L, Kennedy H, Simpson N, Morgan DA, Ellis IO, Cheung KL (2012) Long-term (37 years) clinical outcome of older women with early operable primary breast cancer managed in a dedicated clinic. Ann Oncol 23(6):1465–1471. doi:10.​1093/​annonc/​mdr446 PubMedCrossRef
48.
go back to reference Syed BM, Green AR, Paish EC, Soria D, Garibaldi J, Morgan L, Morgan DA, Ellis IO, Cheung KL (2013) Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts. Br J Cancer 108(5):1042–1051. doi:10.1038/bjc.2012.601 PubMedPubMedCentralCrossRef Syed BM, Green AR, Paish EC, Soria D, Garibaldi J, Morgan L, Morgan DA, Ellis IO, Cheung KL (2013) Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts. Br J Cancer 108(5):1042–1051. doi:10.​1038/​bjc.​2012.​601 PubMedPubMedCentralCrossRef
49.
50.
go back to reference Acevedo F, Camus M, Sanchez C (2015) Breast cancer at extreme ages–a comparative analysis in Chile. Asian Pac J Cancer Prev 16(4):1455–1461PubMedCrossRef Acevedo F, Camus M, Sanchez C (2015) Breast cancer at extreme ages–a comparative analysis in Chile. Asian Pac J Cancer Prev 16(4):1455–1461PubMedCrossRef
51.
go back to reference Inal A, Akman T, Yaman S, Ozturk SC, Geredeli C, Bilici M, Inanc M, Harputoglu H, Demirci U, Balakan O, Cinkir HY, Alici S, Colak D, Sonmez OU, Goksel G, Dogu GG, Engin H, Unal OU, Tamozlu T, Buyukberber S, Boruban CM, Isikdogan A (2014) Pathologic and clinical characteristics of elderly patients with breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology). Int Surg 99(1):2–7. doi:10.9738/INTSURG-D-13-00010 PubMedPubMedCentralCrossRef Inal A, Akman T, Yaman S, Ozturk SC, Geredeli C, Bilici M, Inanc M, Harputoglu H, Demirci U, Balakan O, Cinkir HY, Alici S, Colak D, Sonmez OU, Goksel G, Dogu GG, Engin H, Unal OU, Tamozlu T, Buyukberber S, Boruban CM, Isikdogan A (2014) Pathologic and clinical characteristics of elderly patients with breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology). Int Surg 99(1):2–7. doi:10.​9738/​INTSURG-D-13-00010 PubMedPubMedCentralCrossRef
52.
go back to reference Joerger M, Thurlimann B, Savidan A, Frick H, Rageth C, Lutolf U, Vlastos G, Bouchardy C, Konzelmann I, Bordoni A, Probst-Hensch N, Jundt G, Ess S (2013) Treatment of breast cancer in the elderly: a prospective, population-based Swiss study. J Geriatr Oncol 4(1):39–47. doi:10.1016/j.jgo.2012.08.002 PubMedCrossRef Joerger M, Thurlimann B, Savidan A, Frick H, Rageth C, Lutolf U, Vlastos G, Bouchardy C, Konzelmann I, Bordoni A, Probst-Hensch N, Jundt G, Ess S (2013) Treatment of breast cancer in the elderly: a prospective, population-based Swiss study. J Geriatr Oncol 4(1):39–47. doi:10.​1016/​j.​jgo.​2012.​08.​002 PubMedCrossRef
56.
go back to reference Wildiers H, Van Calster B, van de Poll-Franse LV, Hendrickx W, Roislien J, Smeets A, Paridaens R, Deraedt K, Leunen K, Weltens C, Van Huffel S, Christiaens MR, Neven P (2009) Relationship between age and axillary lymph node involvement in women with breast cancer. J Clin Oncol 27(18):2931–2937. doi:10.1200/JCO.2008.16.7619 PubMedCrossRef Wildiers H, Van Calster B, van de Poll-Franse LV, Hendrickx W, Roislien J, Smeets A, Paridaens R, Deraedt K, Leunen K, Weltens C, Van Huffel S, Christiaens MR, Neven P (2009) Relationship between age and axillary lymph node involvement in women with breast cancer. J Clin Oncol 27(18):2931–2937. doi:10.​1200/​JCO.​2008.​16.​7619 PubMedCrossRef
57.
go back to reference Bastiaannet E, Liefers GJ, de Craen AJ, Kuppen PJ, van de Water W, Portielje JE, van der Geest LG, Janssen-Heijnen ML, Dekkers OM, van de Velde CJ, Westendorp RG (2010) Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treat 124(3):801–807. doi:10.1007/s10549-010-0898-8 PubMedCrossRef Bastiaannet E, Liefers GJ, de Craen AJ, Kuppen PJ, van de Water W, Portielje JE, van der Geest LG, Janssen-Heijnen ML, Dekkers OM, van de Velde CJ, Westendorp RG (2010) Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treat 124(3):801–807. doi:10.​1007/​s10549-010-0898-8 PubMedCrossRef
59.
61.
go back to reference Orucevic A, Curzon M, Curzon C, Heidel RE, McLoughlin JM, Panella T, Bell J (2015) Breast cancer in elderly caucasian women-an institution-based study of correlation between breast cancer prognostic markers, TNM stage, and overall survival. Cancers (Basel) 7(3):1472–1483. doi:10.3390/cancers7030846 CrossRef Orucevic A, Curzon M, Curzon C, Heidel RE, McLoughlin JM, Panella T, Bell J (2015) Breast cancer in elderly caucasian women-an institution-based study of correlation between breast cancer prognostic markers, TNM stage, and overall survival. Cancers (Basel) 7(3):1472–1483. doi:10.​3390/​cancers7030846 CrossRef
62.
go back to reference Siegelmann-Danieli N, Khandelwal V, Wood GC, Mainali R, Prichard J, Murphy TJ, Evans JF, Yumen O, Bernath AM (2006) Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach. Clin Breast Cancer 7(1):59–66. doi:10.3816/CBC.2006.n.014 PubMedCrossRef Siegelmann-Danieli N, Khandelwal V, Wood GC, Mainali R, Prichard J, Murphy TJ, Evans JF, Yumen O, Bernath AM (2006) Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach. Clin Breast Cancer 7(1):59–66. doi:10.​3816/​CBC.​2006.​n.​014 PubMedCrossRef
65.
66.
67.
go back to reference Mathew J, Lee S, Syed BM, Morgan DA, Ellis IO, Cheung KL (2014) A study of ductal versus non-ductal invasive breast carcinomas in older women: long-term clinical outcome and comparison with their younger counterparts. Breast Cancer Res Treat 147(3):671–674. doi:10.1007/s10549-014-3094-4 PubMedCrossRef Mathew J, Lee S, Syed BM, Morgan DA, Ellis IO, Cheung KL (2014) A study of ductal versus non-ductal invasive breast carcinomas in older women: long-term clinical outcome and comparison with their younger counterparts. Breast Cancer Res Treat 147(3):671–674. doi:10.​1007/​s10549-014-3094-4 PubMedCrossRef
71.
go back to reference Haque R, Ahmed SA, Inzhakova G, Shi J, Avila C, Polikoff J, Bernstein L, Enger SM, Press MF (2012) Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades. Cancer Epidemiol Biomark Prev 21(10):1848–1855. doi:10.1158/1055-9965.EPI-12-0474 CrossRef Haque R, Ahmed SA, Inzhakova G, Shi J, Avila C, Polikoff J, Bernstein L, Enger SM, Press MF (2012) Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades. Cancer Epidemiol Biomark Prev 21(10):1848–1855. doi:10.​1158/​1055-9965.​EPI-12-0474 CrossRef
72.
go back to reference Diab SG, Elledge RM, Clark GM (2000) Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92(7):550–556PubMedCrossRef Diab SG, Elledge RM, Clark GM (2000) Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92(7):550–556PubMedCrossRef
73.
go back to reference Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, Gelmon K, Whelan T, Strasser-Weippl K, Rubin S, Sturtz K, Wolff AC, Winer E, Hudis C, Stopeck A, Beck JT, Kaur JS, Whelan K, Tu D, Parulekar WR (2016) Extending aromatase-inhibitor adjuvant therapy to 10 years. N Engl J Med 375(3):209–219. doi:10.1056/NEJMoa1604700 PubMedPubMedCentralCrossRef Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, Gelmon K, Whelan T, Strasser-Weippl K, Rubin S, Sturtz K, Wolff AC, Winer E, Hudis C, Stopeck A, Beck JT, Kaur JS, Whelan K, Tu D, Parulekar WR (2016) Extending aromatase-inhibitor adjuvant therapy to 10 years. N Engl J Med 375(3):209–219. doi:10.​1056/​NEJMoa1604700 PubMedPubMedCentralCrossRef
74.
go back to reference Collaborative Group on Hormonal Factors in Breast C (2012) Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 13(11):1141–1151. doi:10.1016/S1470-2045(12)70425-4 CrossRef Collaborative Group on Hormonal Factors in Breast C (2012) Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 13(11):1141–1151. doi:10.​1016/​S1470-2045(12)70425-4 CrossRef
75.
go back to reference Savolainen-Peltonen H, Vihma V, Leidenius M, Wang F, Turpeinen U, Hamalainen E, Tikkanen MJ, Mikkola TS (2014) Breast adipose tissue estrogen metabolism in postmenopausal women with or without breast cancer. J Clin Endocrinol Metab 99(12):E2661–E2667. doi:10.1210/jc.2014-2550 PubMedCrossRef Savolainen-Peltonen H, Vihma V, Leidenius M, Wang F, Turpeinen U, Hamalainen E, Tikkanen MJ, Mikkola TS (2014) Breast adipose tissue estrogen metabolism in postmenopausal women with or without breast cancer. J Clin Endocrinol Metab 99(12):E2661–E2667. doi:10.​1210/​jc.​2014-2550 PubMedCrossRef
76.
go back to reference Darbre PD (2014) Hypersensitivity and growth adaptation of oestrogen-deprived MCF-7 human breast cancer cells. Anticancer Res 34(1):99–105PubMed Darbre PD (2014) Hypersensitivity and growth adaptation of oestrogen-deprived MCF-7 human breast cancer cells. Anticancer Res 34(1):99–105PubMed
77.
go back to reference Sogaard M, Farkas DK, Ehrenstein V, Jorgensen JO, Dekkers OM, Sorensen HT (2016) Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study. Eur J Endocrinol 174(4):409–414. doi:10.1530/EJE-15-0989 PubMedCrossRef Sogaard M, Farkas DK, Ehrenstein V, Jorgensen JO, Dekkers OM, Sorensen HT (2016) Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study. Eur J Endocrinol 174(4):409–414. doi:10.​1530/​EJE-15-0989 PubMedCrossRef
79.
go back to reference Balducci L (2000) Geriatric oncology: challenges for the new century. Eur J Cancer 36(14):1741–1754PubMedCrossRef Balducci L (2000) Geriatric oncology: challenges for the new century. Eur J Cancer 36(14):1741–1754PubMedCrossRef
80.
go back to reference Raynaud CM, Hernandez J, Llorca FP, Nuciforo P, Mathieu MC, Commo F, Delaloge S, Sabatier L, Andre F, Soria JC (2010) DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer. Am J Clin Oncol 33(4):341–345. doi:10.1097/COC.0b013e3181b0c4c2 PubMedCrossRef Raynaud CM, Hernandez J, Llorca FP, Nuciforo P, Mathieu MC, Commo F, Delaloge S, Sabatier L, Andre F, Soria JC (2010) DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer. Am J Clin Oncol 33(4):341–345. doi:10.​1097/​COC.​0b013e3181b0c4c2​ PubMedCrossRef
81.
go back to reference Radisky DC, Visscher DW, Frank RD, Vierkant RA, Winham S, Stallings-Mann M, Hoskin TL, Nassar A, Vachon CM, Denison LA, Hartmann LC, Frost MH, Degnim AC (2016) Natural history of age-related lobular involution and impact on breast cancer risk. Breast Cancer Res Treat 155(3):423–430. doi:10.1007/s10549-016-3691-5 PubMedPubMedCentralCrossRef Radisky DC, Visscher DW, Frank RD, Vierkant RA, Winham S, Stallings-Mann M, Hoskin TL, Nassar A, Vachon CM, Denison LA, Hartmann LC, Frost MH, Degnim AC (2016) Natural history of age-related lobular involution and impact on breast cancer risk. Breast Cancer Res Treat 155(3):423–430. doi:10.​1007/​s10549-016-3691-5 PubMedPubMedCentralCrossRef
87.
90.
go back to reference Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, Yamada SD, Peter ME, Gwin K, Lengyel E (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17(11):1498–1503. doi:10.1038/nm.2492 PubMedPubMedCentralCrossRef Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, Yamada SD, Peter ME, Gwin K, Lengyel E (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17(11):1498–1503. doi:10.​1038/​nm.​2492 PubMedPubMedCentralCrossRef
94.
go back to reference Andarawewa KL, Motrescu ER, Chenard MP, Gansmuller A, Stoll I, Tomasetto C, Rio MC (2005) Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res 65(23):10862–10871. doi:10.1158/0008-5472.CAN-05-1231 PubMedCrossRef Andarawewa KL, Motrescu ER, Chenard MP, Gansmuller A, Stoll I, Tomasetto C, Rio MC (2005) Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res 65(23):10862–10871. doi:10.​1158/​0008-5472.​CAN-05-1231 PubMedCrossRef
95.
go back to reference Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, Garrido I, Escourrou G, Valet P, Muller C (2011) Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 71(7):2455–2465. doi:10.1158/0008-5472.CAN-10-3323 PubMedCrossRef Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, Garrido I, Escourrou G, Valet P, Muller C (2011) Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 71(7):2455–2465. doi:10.​1158/​0008-5472.​CAN-10-3323 PubMedCrossRef
96.
go back to reference Rio MC, Dali-Youcef N, Tomasetto C (2015) Local adipocyte cancer cell paracrine loop: can “sick fat” be more detrimental? Horm Mol Biol Clin Investig 21(1):43–56. doi:10.1515/hmbci-2014-0044 PubMed Rio MC, Dali-Youcef N, Tomasetto C (2015) Local adipocyte cancer cell paracrine loop: can “sick fat” be more detrimental? Horm Mol Biol Clin Investig 21(1):43–56. doi:10.​1515/​hmbci-2014-0044 PubMed
97.
go back to reference Kimijima I, Ohtake T, Sagara H, Watanabe T, Takenoshita S (2000) Scattered fat invasion: an indicator for poor prognosis in premenopausal, and for positive estrogen receptor in postmenopausal breast cancer patients. Oncology 59(Suppl 1):25–30.PubMedCrossRef Kimijima I, Ohtake T, Sagara H, Watanabe T, Takenoshita S (2000) Scattered fat invasion: an indicator for poor prognosis in premenopausal, and for positive estrogen receptor in postmenopausal breast cancer patients. Oncology 59(Suppl 1):25–30.PubMedCrossRef
99.
101.
go back to reference Falci C, Gianesin K, Sergi G, Giunco S, De Ronch I, Valpione S, Solda C, Fiduccia P, Lonardi S, Zanchetta M, Keppel S, Brunello A, Zafferri V, Manzato E, De Rossi A, Zagonel V (2013) Immune senescence and cancer in elderly patients: results from an exploratory study. Exp Gerontol 48(12):1436–1442. doi:10.1016/j.exger.2013.09.011 PubMedCrossRef Falci C, Gianesin K, Sergi G, Giunco S, De Ronch I, Valpione S, Solda C, Fiduccia P, Lonardi S, Zanchetta M, Keppel S, Brunello A, Zafferri V, Manzato E, De Rossi A, Zagonel V (2013) Immune senescence and cancer in elderly patients: results from an exploratory study. Exp Gerontol 48(12):1436–1442. doi:10.​1016/​j.​exger.​2013.​09.​011 PubMedCrossRef
102.
go back to reference Petkov VI, Miller DP, Howlader N, Gliner N, Howe W, Schussler N, Cronin K, Baehner FL, Cress R, Deapen D, Glaser SL, Hernandez BY, Lynch CF, Mueller L, Schwartz AG, Schwartz SM, Stroup A, Sweeney C, Tucker TC, Ward KC, Wiggins C, Wu XC, Penberthy L, Shak S (2016) Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study. NPJ Breast Cancer 2:16017. doi:10.1038/npjbcancer.2016.17 PubMedPubMedCentralCrossRef Petkov VI, Miller DP, Howlader N, Gliner N, Howe W, Schussler N, Cronin K, Baehner FL, Cress R, Deapen D, Glaser SL, Hernandez BY, Lynch CF, Mueller L, Schwartz AG, Schwartz SM, Stroup A, Sweeney C, Tucker TC, Ward KC, Wiggins C, Wu XC, Penberthy L, Shak S (2016) Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study. NPJ Breast Cancer 2:16017. doi:10.​1038/​npjbcancer.​2016.​17 PubMedPubMedCentralCrossRef
105.
108.
go back to reference Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schafer P, Kurtz J, Sappino AP, Vlastos G (2003) Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 21(19):3580–3587. doi:10.1200/JCO.2003.02.046 PubMedCrossRef Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schafer P, Kurtz J, Sappino AP, Vlastos G (2003) Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 21(19):3580–3587. doi:10.​1200/​JCO.​2003.​02.​046 PubMedCrossRef
Metadata
Title
Breast cancer in elderly women and altered clinico-pathological characteristics: a systematic review
Authors
M. Lodi
L. Scheer
N. Reix
D. Heitz
A.-J. Carin
N. Thiébaut
K. Neuberger
C. Tomasetto
C. Mathelin
Publication date
01-12-2017
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2017
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4448-5

Other articles of this Issue 3/2017

Breast Cancer Research and Treatment 3/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine